Interesting no peer reviewed AVXL trial data. I would like to know why its success is any more or less likely than the examples I have given but haven't seen any in depth trial data that would lead me in either direction. As Alkon mentioned in this interview posted friday, until you read the actual full data set, like KOL have, its very difficult to get the massive possibilities involved here.